CD44-like protein and nucleic acids
US5942417A · kind A · utility
24Cited by
1References
87Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 1997 |
| Grant date | Aug 24, 1999 |
| Priority date | — |
| Expiry date | Jul 15, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns a novel CD44-like protein receptor. In particular, isolated nucleic acid molecules are provided encoding the CD44-like protein. CD44-like polypeptides are also provided, as are screening methods for identifying agonists and antagonists capable of enhancing or inhibiting CD44-like protein-mediated signaling. The invention further concerns therapeutic methods for treating diseases associated with processes mediated by CD44-like protein signaling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.